Evidence mapPaperPMID 28715141Full record

Trial reportDiabetes, obesity & metabolism2018

Walnut consumption increases activation of the insula to highly desirable food cues: A randomized, double-blind, placebo-controlled, cross-over fMRI study.

Olivia M Farr, Dario Tuccinardi, Jagriti Upadhyay, Sabrina M Oussaada, Christos S Mantzoros

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes, obesity & metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Association between walnut consumption and diabetes risk in NHANES.Diabetes/metabolism research and reviews · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Olivia M FarrDivision of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Dario TuccinardiDivision of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Jagriti UpadhyayDivision of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Sabrina M OussaadaDivision of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Christos S MantzorosDivision of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.ORCID 0000-0003-3755-8158
Beth Israel Deaconess Medical Center · US

Funding

NCRR NIH HHS UL1 RR025758NIDDK NIH HHS K24 DK081913
6 · The paper itself

Abstract

aimsThe use of walnuts is recommended for obesity and type 2 diabetes, although the mechanisms through which walnuts may improve appetite control and/or glycaemic control remain largely unknown. MATERIALS AND

methodsTo determine whether short-term walnut consumption could alter the neural control of appetite using functional magnetic resonance imaging, we performed a randomized, placebo-controlled, double-blind, cross-over trial of 10 patients who received, while living in the controlled environment of a clinical research center, either walnuts or placebo (using a validated smoothie delivery system) for 5 days each, separated by a wash-out period of 1 month.

resultsWalnut consumption decreased feelings of hunger and appetite, assessed using visual analog scales, and increased activation of the right insula to highly desirable food cues.

conclusionsThese findings suggest that walnut consumption may increase salience and cognitive control processing of highly desirable food cues, leading to the beneficial metabolic effects observed.

Indexed as

Appetite RegulationFunctional FoodJuglansNutsBody Mass IndexBostonBreakfastCerebral CortexCross-Over StudiesCuesDiabetes Mellitus, Type 2Double-Blind MethodFemaleFood PreferencesHumansMagnetic Resonance Imagingappetite controlobesity therapyrandomised trialtype 2 diabetes

Identifiers

PMID28715141
PMCPMC5720909
OpenAlexW2735489394

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.